Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Accenture
Healthtrust
McKesson
Teva
Covington
QuintilesIMS
Cerilliant
Novartis
Moodys

Generated: January 19, 2018

DrugPatentWatch Database Preview

Betamethasone - Generic Drug Details

« Back to Dashboard

What are the generic sources for betamethasone and what is the scope of betamethasone patent protection?

Betamethasone
is the generic ingredient in twenty-four branded drugs marketed by Schering, Merck Sharp Dohme, Luitpold, Parke Davis, Fougera Pharms, Glenmark Generics, Perrigo New York, Taro, Tolmar, Savage Labs, Actavis Mid Atlantic, Pharmaderm, Teva, Alpharma Us Pharms, Fougera Pharms Inc, G And W Labs Inc, Teligent Pharma Inc, Promius Pharma Llc, Leo Pharma As, Perrigo Israel, Glenmark Pharms, Watson Labs, Perrigo Uk Finco, Riconpharma Llc, Taro Pharm, Mylan Pharms Inc, Roaco, Pharmafair, Sti Pharma Llc, and Teva Pharms, and is included in one hundred and three NDAs. There are nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are sixty-six drug master file entries for betamethasone. There is one tentative approval for this compound.
Medical Subject Heading (MeSH) Categories for betamethasone
Tentative approvals for BETAMETHASONE
Applicant Application No. Strength Dosage Form
➤ Subscribe➤ Subscribe0.12%FOAM;TOPICAL

US Patents and Regulatory Information for betamethasone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Promius Pharma Llc SERNIVO betamethasone dipropionate SPRAY;TOPICAL 208079-001 Feb 5, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Pharmaderm BETAMETHASONE DIPROPIONATE betamethasone dipropionate CREAM;TOPICAL 019136-001 Jun 26, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Mid Atlantic BETAMETHASONE DIPROPIONATE betamethasone dipropionate LOTION;TOPICAL 070281-001 Jul 31, 1985 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Schering DIPROSONE betamethasone dipropionate CREAM;TOPICAL 017536-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Taro BETAMETHASONE DIPROPIONATE betamethasone dipropionate LOTION;TOPICAL 072276-001 Aug 24, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Taro BETAMETHASONE DIPROPIONATE betamethasone dipropionate CREAM, AUGMENTED;TOPICAL 076543-001 Dec 9, 2003 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Luitpold BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE betamethasone acetate; betamethasone sodium phosphate INJECTABLE;INJECTION 090747-001 Jul 31, 2009 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmaderm BETAMETHASONE VALERATE betamethasone valerate OINTMENT;TOPICAL 018864-001 Aug 31, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene hydrate SUSPENSION;TOPICAL 022185-001 May 9, 2008 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Schering VALISONE betamethasone valerate CREAM;TOPICAL 016322-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for betamethasone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering CELESTONE betamethasone CREAM;TOPICAL 014762-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Merck Sharp Dohme CELESTONE betamethasone SYRUP;ORAL 014215-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Schering CELESTONE betamethasone TABLET;ORAL 012657-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
McKesson
Daiichi Sankyo
Cipla
Chubb
Queensland Health
Express Scripts
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot